nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemifloxacin—Eosinophilia—Fluorouracil—skin cancer	0.0018	0.0018	CcSEcCtD
Gemifloxacin—Anorexia—Imiquimod—skin cancer	0.00178	0.00178	CcSEcCtD
Gemifloxacin—Hyperglycaemia—Temozolomide—skin cancer	0.00178	0.00178	CcSEcCtD
Gemifloxacin—Pneumonia—Temozolomide—skin cancer	0.00177	0.00177	CcSEcCtD
Gemifloxacin—Infestation NOS—Temozolomide—skin cancer	0.00176	0.00176	CcSEcCtD
Gemifloxacin—Infestation—Temozolomide—skin cancer	0.00176	0.00176	CcSEcCtD
Gemifloxacin—Blood alkaline phosphatase increased—Docetaxel—skin cancer	0.00174	0.00174	CcSEcCtD
Gemifloxacin—Flushing—Bleomycin—skin cancer	0.00173	0.00173	CcSEcCtD
Gemifloxacin—Body temperature increased—Vemurafenib—skin cancer	0.00173	0.00173	CcSEcCtD
Gemifloxacin—Pharyngitis—Dactinomycin—skin cancer	0.00173	0.00173	CcSEcCtD
Gemifloxacin—Neuropathy peripheral—Temozolomide—skin cancer	0.00172	0.00172	CcSEcCtD
Gemifloxacin—Stomatitis—Temozolomide—skin cancer	0.00171	0.00171	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Imiquimod—skin cancer	0.0017	0.0017	CcSEcCtD
Gemifloxacin—Insomnia—Imiquimod—skin cancer	0.00169	0.00169	CcSEcCtD
Gemifloxacin—Dyspnoea—Imiquimod—skin cancer	0.00167	0.00167	CcSEcCtD
Gemifloxacin—Somnolence—Imiquimod—skin cancer	0.00166	0.00166	CcSEcCtD
Gemifloxacin—Hepatobiliary disease—Temozolomide—skin cancer	0.00166	0.00166	CcSEcCtD
Gemifloxacin—Photosensitivity reaction—Fluorouracil—skin cancer	0.00166	0.00166	CcSEcCtD
Gemifloxacin—Erythema multiforme—Dactinomycin—skin cancer	0.00165	0.00165	CcSEcCtD
Gemifloxacin—Dyspepsia—Imiquimod—skin cancer	0.00165	0.00165	CcSEcCtD
Gemifloxacin—Pneumonia—Fluorouracil—skin cancer	0.00163	0.00163	CcSEcCtD
Gemifloxacin—Decreased appetite—Imiquimod—skin cancer	0.00163	0.00163	CcSEcCtD
Gemifloxacin—Hot flush—Docetaxel—skin cancer	0.00162	0.00162	CcSEcCtD
Gemifloxacin—Infestation NOS—Fluorouracil—skin cancer	0.00162	0.00162	CcSEcCtD
Gemifloxacin—Infestation—Fluorouracil—skin cancer	0.00162	0.00162	CcSEcCtD
Gemifloxacin—Flushing—Dactinomycin—skin cancer	0.00162	0.00162	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Imiquimod—skin cancer	0.00161	0.00161	CcSEcCtD
Gemifloxacin—Fatigue—Imiquimod—skin cancer	0.00161	0.00161	CcSEcCtD
Gemifloxacin—Menopausal symptoms—Docetaxel—skin cancer	0.00161	0.00161	CcSEcCtD
Gemifloxacin—Pain—Imiquimod—skin cancer	0.0016	0.0016	CcSEcCtD
Gemifloxacin—Neuropathy peripheral—Fluorouracil—skin cancer	0.00159	0.00159	CcSEcCtD
Gemifloxacin—Haemoglobin—Temozolomide—skin cancer	0.00158	0.00158	CcSEcCtD
Gemifloxacin—Stomatitis—Fluorouracil—skin cancer	0.00158	0.00158	CcSEcCtD
Gemifloxacin—Haemorrhage—Temozolomide—skin cancer	0.00158	0.00158	CcSEcCtD
Gemifloxacin—Asthenia—Vemurafenib—skin cancer	0.00157	0.00157	CcSEcCtD
Gemifloxacin—Pharyngitis—Temozolomide—skin cancer	0.00157	0.00157	CcSEcCtD
Gemifloxacin—Urinary tract disorder—Temozolomide—skin cancer	0.00156	0.00156	CcSEcCtD
Gemifloxacin—Oedema peripheral—Temozolomide—skin cancer	0.00155	0.00155	CcSEcCtD
Gemifloxacin—Pruritus—Vemurafenib—skin cancer	0.00155	0.00155	CcSEcCtD
Gemifloxacin—Connective tissue disorder—Temozolomide—skin cancer	0.00155	0.00155	CcSEcCtD
Gemifloxacin—Urethral disorder—Temozolomide—skin cancer	0.00155	0.00155	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Imiquimod—skin cancer	0.00153	0.00153	CcSEcCtD
Gemifloxacin—Hyponatraemia—Docetaxel—skin cancer	0.00152	0.00152	CcSEcCtD
Gemifloxacin—Visual impairment—Temozolomide—skin cancer	0.00152	0.00152	CcSEcCtD
Gemifloxacin—Agranulocytosis—Fluorouracil—skin cancer	0.00151	0.00151	CcSEcCtD
Gemifloxacin—Anaemia—Bleomycin—skin cancer	0.0015	0.0015	CcSEcCtD
Gemifloxacin—Diarrhoea—Vemurafenib—skin cancer	0.0015	0.0015	CcSEcCtD
Gemifloxacin—Erythema multiforme—Temozolomide—skin cancer	0.00149	0.00149	CcSEcCtD
Gemifloxacin—Urticaria—Imiquimod—skin cancer	0.00149	0.00149	CcSEcCtD
Gemifloxacin—Abdominal pain—Imiquimod—skin cancer	0.00148	0.00148	CcSEcCtD
Gemifloxacin—Body temperature increased—Imiquimod—skin cancer	0.00148	0.00148	CcSEcCtD
Gemifloxacin—Eye disorder—Temozolomide—skin cancer	0.00147	0.00147	CcSEcCtD
Gemifloxacin—Flushing—Temozolomide—skin cancer	0.00146	0.00146	CcSEcCtD
Gemifloxacin—Cardiac disorder—Temozolomide—skin cancer	0.00146	0.00146	CcSEcCtD
Gemifloxacin—Haemoglobin—Fluorouracil—skin cancer	0.00146	0.00146	CcSEcCtD
Gemifloxacin—Leukopenia—Bleomycin—skin cancer	0.00146	0.00146	CcSEcCtD
Gemifloxacin—Haemorrhage—Fluorouracil—skin cancer	0.00145	0.00145	CcSEcCtD
Gemifloxacin—Dizziness—Vemurafenib—skin cancer	0.00145	0.00145	CcSEcCtD
Gemifloxacin—Pharyngitis—Fluorouracil—skin cancer	0.00144	0.00144	CcSEcCtD
Gemifloxacin—Angiopathy—Temozolomide—skin cancer	0.00143	0.00143	CcSEcCtD
Gemifloxacin—Immune system disorder—Temozolomide—skin cancer	0.00142	0.00142	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Temozolomide—skin cancer	0.00142	0.00142	CcSEcCtD
Gemifloxacin—Anaemia—Dactinomycin—skin cancer	0.0014	0.0014	CcSEcCtD
Gemifloxacin—Vomiting—Vemurafenib—skin cancer	0.00139	0.00139	CcSEcCtD
Gemifloxacin—Myalgia—Bleomycin—skin cancer	0.00139	0.00139	CcSEcCtD
Gemifloxacin—Rash—Vemurafenib—skin cancer	0.00138	0.00138	CcSEcCtD
Gemifloxacin—Mental disorder—Temozolomide—skin cancer	0.00138	0.00138	CcSEcCtD
Gemifloxacin—Dermatitis—Vemurafenib—skin cancer	0.00138	0.00138	CcSEcCtD
Gemifloxacin—Headache—Vemurafenib—skin cancer	0.00137	0.00137	CcSEcCtD
Gemifloxacin—Breast disorder—Docetaxel—skin cancer	0.00137	0.00137	CcSEcCtD
Gemifloxacin—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.00137	0.00137	CcSEcCtD
Gemifloxacin—Leukopenia—Dactinomycin—skin cancer	0.00136	0.00136	CcSEcCtD
Gemifloxacin—Dysgeusia—Temozolomide—skin cancer	0.00134	0.00134	CcSEcCtD
Gemifloxacin—Asthenia—Imiquimod—skin cancer	0.00134	0.00134	CcSEcCtD
Gemifloxacin—Alanine aminotransferase increased—Docetaxel—skin cancer	0.00134	0.00134	CcSEcCtD
Gemifloxacin—Oedema—Bleomycin—skin cancer	0.00133	0.00133	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Bleomycin—skin cancer	0.00133	0.00133	CcSEcCtD
Gemifloxacin—Back pain—Temozolomide—skin cancer	0.00133	0.00133	CcSEcCtD
Gemifloxacin—Pruritus—Imiquimod—skin cancer	0.00132	0.00132	CcSEcCtD
Gemifloxacin—Dysphagia—Docetaxel—skin cancer	0.00131	0.00131	CcSEcCtD
Gemifloxacin—Nausea—Vemurafenib—skin cancer	0.0013	0.0013	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Bleomycin—skin cancer	0.0013	0.0013	CcSEcCtD
Gemifloxacin—Myalgia—Dactinomycin—skin cancer	0.00129	0.00129	CcSEcCtD
Gemifloxacin—Tremor—Temozolomide—skin cancer	0.00129	0.00129	CcSEcCtD
Gemifloxacin—Diarrhoea—Imiquimod—skin cancer	0.00128	0.00128	CcSEcCtD
Gemifloxacin—Anaemia—Temozolomide—skin cancer	0.00127	0.00127	CcSEcCtD
Gemifloxacin—Anorexia—Bleomycin—skin cancer	0.00127	0.00127	CcSEcCtD
Gemifloxacin—Oedema—Dactinomycin—skin cancer	0.00124	0.00124	CcSEcCtD
Gemifloxacin—Dizziness—Imiquimod—skin cancer	0.00124	0.00124	CcSEcCtD
Gemifloxacin—Vertigo—Temozolomide—skin cancer	0.00123	0.00123	CcSEcCtD
Gemifloxacin—Leukopenia—Temozolomide—skin cancer	0.00123	0.00123	CcSEcCtD
Gemifloxacin—Palpitations—Temozolomide—skin cancer	0.00121	0.00121	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Dactinomycin—skin cancer	0.00121	0.00121	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00121	0.00121	CcSEcCtD
Gemifloxacin—Vomiting—Imiquimod—skin cancer	0.00119	0.00119	CcSEcCtD
Gemifloxacin—Dyspnoea—Bleomycin—skin cancer	0.00118	0.00118	CcSEcCtD
Gemifloxacin—Anorexia—Dactinomycin—skin cancer	0.00118	0.00118	CcSEcCtD
Gemifloxacin—Rash—Imiquimod—skin cancer	0.00118	0.00118	CcSEcCtD
Gemifloxacin—Dermatitis—Imiquimod—skin cancer	0.00118	0.00118	CcSEcCtD
Gemifloxacin—Pneumonia—Docetaxel—skin cancer	0.00117	0.00117	CcSEcCtD
Gemifloxacin—Headache—Imiquimod—skin cancer	0.00117	0.00117	CcSEcCtD
Gemifloxacin—Anaemia—Fluorouracil—skin cancer	0.00117	0.00117	CcSEcCtD
Gemifloxacin—Arthralgia—Temozolomide—skin cancer	0.00117	0.00117	CcSEcCtD
Gemifloxacin—Myalgia—Temozolomide—skin cancer	0.00117	0.00117	CcSEcCtD
Gemifloxacin—Infestation—Docetaxel—skin cancer	0.00117	0.00117	CcSEcCtD
Gemifloxacin—Infestation NOS—Docetaxel—skin cancer	0.00117	0.00117	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.00116	0.00116	CcSEcCtD
Gemifloxacin—Decreased appetite—Bleomycin—skin cancer	0.00115	0.00115	CcSEcCtD
Gemifloxacin—Renal failure—Docetaxel—skin cancer	0.00115	0.00115	CcSEcCtD
Gemifloxacin—Neuropathy peripheral—Docetaxel—skin cancer	0.00115	0.00115	CcSEcCtD
Gemifloxacin—Dry mouth—Temozolomide—skin cancer	0.00114	0.00114	CcSEcCtD
Gemifloxacin—Stomatitis—Docetaxel—skin cancer	0.00114	0.00114	CcSEcCtD
Gemifloxacin—Pain—Bleomycin—skin cancer	0.00114	0.00114	CcSEcCtD
Gemifloxacin—Leukopenia—Fluorouracil—skin cancer	0.00113	0.00113	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00113	0.00113	CcSEcCtD
Gemifloxacin—Oedema—Temozolomide—skin cancer	0.00112	0.00112	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Temozolomide—skin cancer	0.00112	0.00112	CcSEcCtD
Gemifloxacin—Nausea—Imiquimod—skin cancer	0.00111	0.00111	CcSEcCtD
Gemifloxacin—Hepatobiliary disease—Docetaxel—skin cancer	0.0011	0.0011	CcSEcCtD
Gemifloxacin—Nervous system disorder—Temozolomide—skin cancer	0.0011	0.0011	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Temozolomide—skin cancer	0.0011	0.0011	CcSEcCtD
Gemifloxacin—Agranulocytosis—Docetaxel—skin cancer	0.00109	0.00109	CcSEcCtD
Gemifloxacin—Skin disorder—Temozolomide—skin cancer	0.00109	0.00109	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Temozolomide—skin cancer	0.00108	0.00108	CcSEcCtD
Gemifloxacin—Myalgia—Fluorouracil—skin cancer	0.00108	0.00108	CcSEcCtD
Gemifloxacin—Decreased appetite—Dactinomycin—skin cancer	0.00108	0.00108	CcSEcCtD
Gemifloxacin—Fatigue—Dactinomycin—skin cancer	0.00107	0.00107	CcSEcCtD
Gemifloxacin—Anorexia—Temozolomide—skin cancer	0.00107	0.00107	CcSEcCtD
Gemifloxacin—Pain—Dactinomycin—skin cancer	0.00106	0.00106	CcSEcCtD
Gemifloxacin—Urticaria—Bleomycin—skin cancer	0.00106	0.00106	CcSEcCtD
Gemifloxacin—Haemoglobin—Docetaxel—skin cancer	0.00105	0.00105	CcSEcCtD
Gemifloxacin—Body temperature increased—Bleomycin—skin cancer	0.00105	0.00105	CcSEcCtD
Gemifloxacin—Haemorrhage—Docetaxel—skin cancer	0.00105	0.00105	CcSEcCtD
Gemifloxacin—Pharyngitis—Docetaxel—skin cancer	0.00104	0.00104	CcSEcCtD
Gemifloxacin—Urinary tract disorder—Docetaxel—skin cancer	0.00104	0.00104	CcSEcCtD
Gemifloxacin—Oedema peripheral—Docetaxel—skin cancer	0.00103	0.00103	CcSEcCtD
Gemifloxacin—Oedema—Fluorouracil—skin cancer	0.00103	0.00103	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Fluorouracil—skin cancer	0.00103	0.00103	CcSEcCtD
Gemifloxacin—Connective tissue disorder—Docetaxel—skin cancer	0.00103	0.00103	CcSEcCtD
Gemifloxacin—Urethral disorder—Docetaxel—skin cancer	0.00103	0.00103	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00102	0.00102	CcSEcCtD
Gemifloxacin—Insomnia—Temozolomide—skin cancer	0.00101	0.00101	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Dactinomycin—skin cancer	0.00101	0.00101	CcSEcCtD
Gemifloxacin—Nervous system disorder—Fluorouracil—skin cancer	0.00101	0.00101	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Fluorouracil—skin cancer	0.00101	0.00101	CcSEcCtD
Gemifloxacin—Visual impairment—Docetaxel—skin cancer	0.00101	0.00101	CcSEcCtD
Gemifloxacin—Tachycardia—Fluorouracil—skin cancer	0.00101	0.00101	CcSEcCtD
Gemifloxacin—Dyspnoea—Temozolomide—skin cancer	0.000999	0.000999	CcSEcCtD
Gemifloxacin—Somnolence—Temozolomide—skin cancer	0.000996	0.000996	CcSEcCtD
Gemifloxacin—Erythema multiforme—Docetaxel—skin cancer	0.000992	0.000992	CcSEcCtD
Gemifloxacin—Dyspepsia—Temozolomide—skin cancer	0.000986	0.000986	CcSEcCtD
Gemifloxacin—Anorexia—Fluorouracil—skin cancer	0.000984	0.000984	CcSEcCtD
Gemifloxacin—Eye disorder—Docetaxel—skin cancer	0.00098	0.00098	CcSEcCtD
Gemifloxacin—Body temperature increased—Dactinomycin—skin cancer	0.000979	0.000979	CcSEcCtD
Gemifloxacin—Abdominal pain—Dactinomycin—skin cancer	0.000979	0.000979	CcSEcCtD
Gemifloxacin—Decreased appetite—Temozolomide—skin cancer	0.000974	0.000974	CcSEcCtD
Gemifloxacin—Cardiac disorder—Docetaxel—skin cancer	0.000973	0.000973	CcSEcCtD
Gemifloxacin—Flushing—Docetaxel—skin cancer	0.000973	0.000973	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Temozolomide—skin cancer	0.000967	0.000967	CcSEcCtD
Gemifloxacin—Fatigue—Temozolomide—skin cancer	0.000966	0.000966	CcSEcCtD
Gemifloxacin—Pain—Temozolomide—skin cancer	0.000958	0.000958	CcSEcCtD
Gemifloxacin—Constipation—Temozolomide—skin cancer	0.000958	0.000958	CcSEcCtD
Gemifloxacin—Asthenia—Bleomycin—skin cancer	0.000953	0.000953	CcSEcCtD
Gemifloxacin—Angiopathy—Docetaxel—skin cancer	0.000951	0.000951	CcSEcCtD
Gemifloxacin—Immune system disorder—Docetaxel—skin cancer	0.000947	0.000947	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Docetaxel—skin cancer	0.000945	0.000945	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00094	0.00094	CcSEcCtD
Gemifloxacin—Pruritus—Bleomycin—skin cancer	0.00094	0.00094	CcSEcCtD
Gemifloxacin—Insomnia—Fluorouracil—skin cancer	0.000934	0.000934	CcSEcCtD
Gemifloxacin—Dyspnoea—Fluorouracil—skin cancer	0.00092	0.00092	CcSEcCtD
Gemifloxacin—Mental disorder—Docetaxel—skin cancer	0.000919	0.000919	CcSEcCtD
Gemifloxacin—Somnolence—Fluorouracil—skin cancer	0.000918	0.000918	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Temozolomide—skin cancer	0.000916	0.000916	CcSEcCtD
Gemifloxacin—Dyspepsia—Fluorouracil—skin cancer	0.000909	0.000909	CcSEcCtD
Gemifloxacin—Decreased appetite—Fluorouracil—skin cancer	0.000897	0.000897	CcSEcCtD
Gemifloxacin—Dysgeusia—Docetaxel—skin cancer	0.000894	0.000894	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000891	0.000891	CcSEcCtD
Gemifloxacin—Urticaria—Temozolomide—skin cancer	0.00089	0.00089	CcSEcCtD
Gemifloxacin—Asthenia—Dactinomycin—skin cancer	0.000889	0.000889	CcSEcCtD
Gemifloxacin—Abdominal pain—Temozolomide—skin cancer	0.000886	0.000886	CcSEcCtD
Gemifloxacin—Body temperature increased—Temozolomide—skin cancer	0.000886	0.000886	CcSEcCtD
Gemifloxacin—Back pain—Docetaxel—skin cancer	0.000883	0.000883	CcSEcCtD
Gemifloxacin—Pain—Fluorouracil—skin cancer	0.000883	0.000883	CcSEcCtD
Gemifloxacin—Muscle spasms—Docetaxel—skin cancer	0.000878	0.000878	CcSEcCtD
Gemifloxacin—Diarrhoea—Dactinomycin—skin cancer	0.000848	0.000848	CcSEcCtD
Gemifloxacin—Vomiting—Bleomycin—skin cancer	0.000844	0.000844	CcSEcCtD
Gemifloxacin—Anaemia—Docetaxel—skin cancer	0.000844	0.000844	CcSEcCtD
Gemifloxacin—Rash—Bleomycin—skin cancer	0.000837	0.000837	CcSEcCtD
Gemifloxacin—Dermatitis—Bleomycin—skin cancer	0.000837	0.000837	CcSEcCtD
Gemifloxacin—Urticaria—Fluorouracil—skin cancer	0.00082	0.00082	CcSEcCtD
Gemifloxacin—Syncope—Docetaxel—skin cancer	0.000819	0.000819	CcSEcCtD
Gemifloxacin—Leukopenia—Docetaxel—skin cancer	0.000817	0.000817	CcSEcCtD
Gemifloxacin—Body temperature increased—Fluorouracil—skin cancer	0.000816	0.000816	CcSEcCtD
Gemifloxacin—Palpitations—Docetaxel—skin cancer	0.000807	0.000807	CcSEcCtD
Gemifloxacin—Asthenia—Temozolomide—skin cancer	0.000804	0.000804	CcSEcCtD
Gemifloxacin—Loss of consciousness—Docetaxel—skin cancer	0.000802	0.000802	CcSEcCtD
Gemifloxacin—Pruritus—Temozolomide—skin cancer	0.000793	0.000793	CcSEcCtD
Gemifloxacin—Nausea—Bleomycin—skin cancer	0.000789	0.000789	CcSEcCtD
Gemifloxacin—Vomiting—Dactinomycin—skin cancer	0.000788	0.000788	CcSEcCtD
Gemifloxacin—Rash—Dactinomycin—skin cancer	0.000781	0.000781	CcSEcCtD
Gemifloxacin—Myalgia—Docetaxel—skin cancer	0.000777	0.000777	CcSEcCtD
Gemifloxacin—Arthralgia—Docetaxel—skin cancer	0.000777	0.000777	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000772	0.000772	CcSEcCtD
Gemifloxacin—Diarrhoea—Temozolomide—skin cancer	0.000767	0.000767	CcSEcCtD
Gemifloxacin—Dry mouth—Docetaxel—skin cancer	0.00076	0.00076	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Docetaxel—skin cancer	0.000745	0.000745	CcSEcCtD
Gemifloxacin—Oedema—Docetaxel—skin cancer	0.000745	0.000745	CcSEcCtD
Gemifloxacin—Dizziness—Temozolomide—skin cancer	0.000741	0.000741	CcSEcCtD
Gemifloxacin—Nausea—Dactinomycin—skin cancer	0.000736	0.000736	CcSEcCtD
Gemifloxacin—Shock—Docetaxel—skin cancer	0.000733	0.000733	CcSEcCtD
Gemifloxacin—Nervous system disorder—Docetaxel—skin cancer	0.000731	0.000731	CcSEcCtD
Gemifloxacin—Pruritus—Fluorouracil—skin cancer	0.00073	0.00073	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Docetaxel—skin cancer	0.000729	0.000729	CcSEcCtD
Gemifloxacin—Tachycardia—Docetaxel—skin cancer	0.000727	0.000727	CcSEcCtD
Gemifloxacin—Skin disorder—Docetaxel—skin cancer	0.000724	0.000724	CcSEcCtD
Gemifloxacin—Vomiting—Temozolomide—skin cancer	0.000712	0.000712	CcSEcCtD
Gemifloxacin—Anorexia—Docetaxel—skin cancer	0.00071	0.00071	CcSEcCtD
Gemifloxacin—Rash—Temozolomide—skin cancer	0.000706	0.000706	CcSEcCtD
Gemifloxacin—Diarrhoea—Fluorouracil—skin cancer	0.000706	0.000706	CcSEcCtD
Gemifloxacin—Dermatitis—Temozolomide—skin cancer	0.000706	0.000706	CcSEcCtD
Gemifloxacin—Headache—Temozolomide—skin cancer	0.000702	0.000702	CcSEcCtD
Gemifloxacin—Dizziness—Fluorouracil—skin cancer	0.000683	0.000683	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000679	0.000679	CcSEcCtD
Gemifloxacin—Insomnia—Docetaxel—skin cancer	0.000674	0.000674	CcSEcCtD
Gemifloxacin—Nausea—Temozolomide—skin cancer	0.000665	0.000665	CcSEcCtD
Gemifloxacin—Dyspnoea—Docetaxel—skin cancer	0.000664	0.000664	CcSEcCtD
Gemifloxacin—Somnolence—Docetaxel—skin cancer	0.000662	0.000662	CcSEcCtD
Gemifloxacin—Vomiting—Fluorouracil—skin cancer	0.000656	0.000656	CcSEcCtD
Gemifloxacin—Dyspepsia—Docetaxel—skin cancer	0.000656	0.000656	CcSEcCtD
Gemifloxacin—Rash—Fluorouracil—skin cancer	0.000651	0.000651	CcSEcCtD
Gemifloxacin—Dermatitis—Fluorouracil—skin cancer	0.00065	0.00065	CcSEcCtD
Gemifloxacin—Decreased appetite—Docetaxel—skin cancer	0.000648	0.000648	CcSEcCtD
Gemifloxacin—Headache—Fluorouracil—skin cancer	0.000647	0.000647	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Docetaxel—skin cancer	0.000643	0.000643	CcSEcCtD
Gemifloxacin—Fatigue—Docetaxel—skin cancer	0.000642	0.000642	CcSEcCtD
Gemifloxacin—Pain—Docetaxel—skin cancer	0.000637	0.000637	CcSEcCtD
Gemifloxacin—Constipation—Docetaxel—skin cancer	0.000637	0.000637	CcSEcCtD
Gemifloxacin—Nausea—Fluorouracil—skin cancer	0.000613	0.000613	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Docetaxel—skin cancer	0.000609	0.000609	CcSEcCtD
Gemifloxacin—Abdominal pain—Docetaxel—skin cancer	0.000589	0.000589	CcSEcCtD
Gemifloxacin—Body temperature increased—Docetaxel—skin cancer	0.000589	0.000589	CcSEcCtD
Gemifloxacin—Asthenia—Docetaxel—skin cancer	0.000535	0.000535	CcSEcCtD
Gemifloxacin—Pruritus—Docetaxel—skin cancer	0.000527	0.000527	CcSEcCtD
Gemifloxacin—Diarrhoea—Docetaxel—skin cancer	0.00051	0.00051	CcSEcCtD
Gemifloxacin—Dizziness—Docetaxel—skin cancer	0.000493	0.000493	CcSEcCtD
Gemifloxacin—Vomiting—Docetaxel—skin cancer	0.000474	0.000474	CcSEcCtD
Gemifloxacin—Rash—Docetaxel—skin cancer	0.00047	0.00047	CcSEcCtD
Gemifloxacin—Dermatitis—Docetaxel—skin cancer	0.000469	0.000469	CcSEcCtD
Gemifloxacin—Headache—Docetaxel—skin cancer	0.000467	0.000467	CcSEcCtD
Gemifloxacin—Nausea—Docetaxel—skin cancer	0.000443	0.000443	CcSEcCtD
